XWELL, Inc. - Common Stock (XWEL)

Synergy CHC Corp. (NASDAQ: SNYR) stands out with the nationwide rollout of FocusFactor® Ready-to-Drink Beverage, entering the multi-billion-dollar U.S. energy drink and functional beverage market — one of the fastest-growing segments in consumer health and wellness.

As investors search for “stocks under $1 to buy now,” “small-cap breakout stocks 2026,” “AI education stocks,” “wellness growth stocks,” “organic grocery expansion,” and “microcap acquisition targets,” several emerging companies across Nasdaq, NYSE American, and OTC markets are generating renewed attention.

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) --  Today, CPC Pain & Wellness SPV, LLC (“CPC”), a significant XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”) shareholder that beneficially owns 394,200 or 9.42% of XWELL’s outstanding shares, issued the below letter to its fellow shareholders. The letter informs shareholders of CPC’s recent lawsuit filing against the incumbent members of XWELL’s Board of Directors for breach of their fiduciary duties and for the Board’s wrongful and inequitable efforts to prevent CPC from nominating a competing slate of directors and consequently denying shareholders the opportunity to choose who they elect to XWELL’s Board at the upcoming annual shareholder meeting. In its letter, CPC details how current Board members have personally benefited from XWELL while overseeing an astounding decline in XWELL shareholder value and substantial net losses. CPC also shares in the below letter its vision for restoring and maximizing shareholder value.

XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced that the notice materials submitted by CPC Pain & Wellness SPV, LLC (“CPC”), which purported to provide notice of CPC’s intent to nominate four candidates for election to the Company’s five-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders, is invalid.